| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Hagler Mark Arnold serves as a See Remarks at NBP. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $577K at current prices.
The biggest single holding is NBP (~$577K) as See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 230,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | NBP Novabridge Biosciences | See Remarks | Buy | 230,000 | $2.51 | $577,300.00 | New | -27.8% | - |